<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000641162"><TermName>tumor necrosis factor-related apoptosis-inducing ligand</TermName><TermPronunciation>(TOO-mer neh-KROH-sis FAK-ter-ree-LAY-ted A-pop-TOH-sis-in-DOO-sing LIH-gund)</TermPronunciation><TermDefinition><DefinitionText>A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. Tumor necrosis factor-related apoptosis-inducing ligand is being studied in the treatment of cancer. Also called Apo-2L, TNF-related apoptosis-inducing ligand,  and TRAIL.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722837" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tumor necrosis factor-related apoptosis-inducing ligand&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722838" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ligando inductor de apoptosis relacionada con el factor de necrosis tumoral&quot;" language="es" id="_4"/><SpanishTermName>ligando inductor de apoptosis relacionada con el factor de necrosis tumoral</SpanishTermName><SpanishTermDefinition><DefinitionText>Proteína celular que se puede unir a ciertas moléculas de algunas células cancerosas y puede destruir las células. El ligando inductor de apoptosis relacionada con el factor de necrosis tumoral está en estudio para el tratamiento de cáncer. También se llama Apo-2L, ligando inductor de apoptosis relacionada con el FNT,  y TRAIL.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-05-08</DateFirstPublished></GlossaryTerm>
